awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34483953-03933569-C758-4471-B63D-DCAB91B562FC
Q34483953-03933569-C758-4471-B63D-DCAB91B562FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34483953-03933569-C758-4471-B63D-DCAB91B562FC
Emerging treatment for advanced lung cancer with EGFR mutation.
P2860
Q34483953-03933569-C758-4471-B63D-DCAB91B562FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34483953-03933569-C758-4471-B63D-DCAB91B562FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d80c99bf0cac53e0fe471b231271cfdac475290
P2860
LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both.